Select Page

IDKmonitor® Adalimumab Drug Level ELISA


Enzyme immunoassay intended for the quantitative determination of free adalimumab (therapeutic antibody against TNFα, e.g. HUMIRA®).

Add to Quote
Product Added to Quote
View Quote Basket
SKU: K9657 Category:


The IDKmonitor® adalimumab drug level ELISA measures quantitatively free adalimumab in EDTA plasma and serum.

Tumor necrosis factor alpha (TNFα) belongs to the proinflammatory cytokines, which promote and sustain inflammatory reactions. It is produced by macrophages and T-cells and plays a central role in both acute and chronic inflammations. As a result, chronic inflammatory diseases like Crohn’s disease, ulcerative colitis, rheumatoid arthritis, or psoriasis are increasingly being treated with antibodies against TNFa, which target directly the underlying inflammatory processes.

In combination with the detection of ADA against adalimumab, the IDKmonitor® adalimumab drug level ELISA is an opportunity for the treating physician to monitor and
optimize the therapy early on.

You may also like…

  • Product Code:


  • Brand:

    Immundiagnostik AG

  • Assay Type:

    ELISA (Enzyme Immunoassay)

  • Sample Types(s):

    Plasma, Serum

  • Regulatory Status:

    Health Canada Device License